BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37003132)

  • 1. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
    Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
    Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
    Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma.
    Zhao F; Yu W; Hu J; Xia Y; Li Y; Liu S; Liu A; Wang C; Zhang H; Zhang L; Shi J
    Eur J Pharmacol; 2024 Jul; 974():176601. PubMed ID: 38677534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
    Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
    Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
    Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
    Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma.
    Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P
    Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis.
    Fei M; Guan J; Xue T; Qin L; Tang C; Cui G; Wang Y; Gong H; Feng W
    Cell Mol Biol Lett; 2018; 23():46. PubMed ID: 30258464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage.
    Luo D; Wang Y; Zhang M; Li H; Zhao D; Li H; Chen X; Jin C; Han B
    Cell Death Dis; 2022 Nov; 13(11):918. PubMed ID: 36319626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of hypoxia inducible factor-1α on P311 and its influence on the migration of murine epidermal stem cells].
    Xu ZD; Li HS; Wang S; He WF; Wu J; Luo GX
    Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):287-294. PubMed ID: 28651420
    [No Abstract]   [Full Text] [Related]  

  • 19. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
    Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
    Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.